Skip to main navigation Skip to search Skip to main content

Abstract

Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.

Original languageEnglish (US)
Pages (from-to)731-738
Number of pages8
JournalJournal of Surgical Oncology
Volume105
Issue number7
DOIs
StatePublished - Jun 1 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Multidisciplinary management of malignant pleural effusion'. Together they form a unique fingerprint.

Cite this